| 000 | 01300 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250516203420.0 | ||
| 264 | 0 | _c20141205 | |
| 008 | 201412s 0 0 ger d | ||
| 022 | _a1435-1250 | ||
| 024 | 7 |
_a10.1007/s00393-013-1238-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRubbert-Roth, A | |
| 245 | 0 | 0 |
_a[Recommendations for use of rituximab in patients with rheumatoid arthritis]. _h[electronic resource] |
| 260 |
_bZeitschrift fur Rheumatologie _cMar 2014 |
||
| 300 |
_a165-74 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Murine-Derived _xadministration & dosage |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aGermany |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aRheumatology _xstandards |
| 650 | 0 | 4 | _aRituximab |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aBurmester, G R | |
| 700 | 1 | _aDörner, T | |
| 700 | 1 | _aGause, A | |
| 773 | 0 |
_tZeitschrift fur Rheumatologie _gvol. 73 _gno. 2 _gp. 165-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00393-013-1238-2 _zAvailable from publisher's website |
| 999 |
_c23667326 _d23667326 |
||